Insider · CIK 0001645514
Daniel Hume
Files at TGTX (TG THERAPEUTICS, INC.). First filing -, latest -.
Daniel Hume files SEC Form 4 as director at TGTX (TG THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Daniel Hume has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | TGTX TG THERAPEUTICS, INC. | AGrant or award Common Stock | +14,718 | $0.00 | $0 | 192,748 | Jun 16, 2025 |
| Mar 17, 2025 | TGTX TG THERAPEUTICS, INC. | GGift Common Stock | -62,459 | $0.00 | $0 | 178,030 | Mar 18, 2025 |
Questions about Daniel Hume
Answered from the filings on this page, as of the latest one.
Is Daniel Hume buying or selling?
Daniel Hume has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Daniel Hume's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel Hume has 0.
Where does Daniel Hume file Form 4?
Daniel Hume has filed Form 4 at TGTX (TG THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.